The HCPLive hospital medicine page is a comprehensive resource for clinical news and insights on the emergency medicine specialty. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for emergent care, and more.
November 10th 2024
A Q&A with a pediatric gastroenterologist on new data detailing trends in water bead injuries in the US from 2013 through 2023.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
No Benefit from Niacin in Seniors with Coronary Artery Disease
November 25th 2009A study from Johns Hopkins has found that "routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease."
Translating Education into Clinical Practice: The Role of Learning Communities
November 24th 2009Collaboration is important in healthcare, as evidenced by the growing number of "learning communities" and grassroots efforts that are bringing people and organizations together to work on the issue of eliminating disparities in health and healthcare.
Revised AHA/ACC PCI and STEMI Guidelines Released
November 18th 2009Wednesday at the American Heart Association Scientific Sessions 2009, the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines announced the release of the long-awaited update to the guidelines for management of patients with ST-elevation myocardial infarction and the management of patients undergoing percutaneous coronary intervention.
What Can Ischemia and Ventricular Tachycardia Tell Us about Cardiovascular Risk?
November 17th 2009Study results from the MERLIN-TIMI 36 Trial looking at the risk of ischemia and nonsustained ventricular tachycardia (NSVT) alone or combined in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) were presented during an abstract oral session at the American Heart Association Scientific Sessions 2009.
Coronary Micro-vessel Spasm and Angina-like Chest Pain
November 17th 2009A study presented Tuesday at the American Heart Association Scientific Sessions 2009 looked at the relationship between coronary micro-vessel spasm, epicardial coronary artery spastic angina, and non-obstructive coronary artery disease.
The pundits are going to have their field day with this one. "The danger [with this Bill] is that as costs continue to rise and coverage becomes less comprehensive, people will conclude that we've tried health reform and it didn't work. But the real problem will be that we didn't really try it.
‘Paradigm Shift' Needed in Disease Control to Account for Human Mobility
October 29th 2009A researcher at McMaster University, in collaboration with a team of international scientists, has proposed that a “paradigm shift” needs to occur in disease control that focuses more on the impact that human travel can have on the moving of drug-resistant infectious diseases around the world.